Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cipla
Healthtrust
Teva
Merck
Express Scripts
Mallinckrodt
QuintilesIMS
Novartis
Baxter

Generated: February 18, 2018

DrugPatentWatch Database Preview

Forest Labs Company Profile

« Back to Dashboard

What is the competitive landscape for FOREST LABS, and what generic alternatives to FOREST LABS drugs are available?

FOREST LABS has twenty-four approved drugs.

There are twenty-two US patents protecting FOREST LABS drugs and there have been four Paragraph IV challenges on FOREST LABS drugs in the past three years.

There are ninety-one patent family members on FOREST LABS drugs in twenty-seven countries and six supplementary protection certificates in four countries.

Summary for Forest Labs
International Patents:91
US Patents:22
Tradenames:27
Ingredients:16
NDAs:24

Drugs and US Patents for Forest Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs Llc NAMZARIC donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206439-002 Dec 23, 2014 AB RX Yes Yes 8,168,209*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Inc VIOKACE pancrelipase (amylase;lipase;protease) TABLET;ORAL 022542-002 Mar 1, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Forest Labs Llc SAPHRIS asenapine maleate TABLET;SUBLINGUAL 022117-002 Aug 13, 2009 RX Yes Yes 7,741,358*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Llc SAPHRIS asenapine maleate TABLET;SUBLINGUAL 022117-003 Mar 12, 2015 RX Yes No 8,022,228*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Llc NAMENDA XR memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022525-003 Jun 21, 2010 AB RX Yes No 8,362,085*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Llc SAPHRIS asenapine maleate TABLET;SUBLINGUAL 022117-003 Mar 12, 2015 RX Yes No 5,763,476*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Inc ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-002 Aug 27, 2009 RX Yes No 8,562,981 ➤ Try a Free Trial ➤ Try a Free Trial
Forest Labs Llc NAMZARIC donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206439-001 Dec 23, 2014 AB RX Yes No 8,329,752*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Inc ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-004 Aug 27, 2009 RX Yes No 8,246,950 ➤ Try a Free Trial ➤ Try a Free Trial
Forest Labs Llc NAMZARIC donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206439-003 Jul 18, 2016 RX Yes No 8,058,291 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Forest Labs

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs Llc NAMENDA XR memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022525-001 Jun 21, 2010 5,061,703*PED ➤ Try a Free Trial
Forest Labs Llc NAMENDA XR memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022525-002 Jun 21, 2010 5,061,703*PED ➤ Try a Free Trial
Forest Labs COMBUNOX ibuprofen; oxycodone hydrochloride TABLET;ORAL 021378-001 Nov 26, 2004 4,569,937 ➤ Try a Free Trial
Forest Labs Llc NAMENDA XR memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022525-003 Jun 21, 2010 5,061,703*PED ➤ Try a Free Trial
Forest Labs Llc NAMENDA XR memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022525-004 Jun 21, 2010 5,061,703*PED ➤ Try a Free Trial
Forest Labs Llc NAMZARIC donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206439-002 Dec 23, 2014 5,061,703*PED ➤ Try a Free Trial
Forest Labs Inc URSO 250 ursodiol TABLET;ORAL 020675-001 Dec 10, 1997 4,859,660 ➤ Try a Free Trial
Forest Labs Llc NAMZARIC donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206439-001 Dec 23, 2014 5,061,703*PED ➤ Try a Free Trial
Forest Labs Inc URSO FORTE ursodiol TABLET;ORAL 020675-002 Jul 21, 2004 4,859,660 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for FOREST LABS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Sublingual Tablets 2.5 mg ➤ Subscribe 7/27/2017
➤ Subscribe Capsules 7 mg/10 mg ➤ Subscribe 9/26/2016
➤ Subscribe Capsules 21 mg/10 mg ➤ Subscribe 9/23/2016
➤ Subscribe Capsules 14 mg/10 mg and 28 mg/10 mg ➤ Subscribe 5/18/2015
➤ Subscribe Extended-release Capsules 7 mg, 14 mg, 21 mg, and 28 mg ➤ Subscribe 8/16/2013
➤ Subscribe Sublingual Tablets 5 mg and 10 mg ➤ Subscribe 8/13/2013
➤ Subscribe Extended-release Capsules 7 mg, 14 mg, 21 mg ➤ Subscribe 6/17/2013
➤ Subscribe Extended-release Capsules 28 mg ➤ Subscribe 6/12/2013
➤ Subscribe Extended-release Capsules 7 mg, 14 mg, 21 mg, and 28 mg ➤ Subscribe 6/10/2013

Non-Orange Book US Patents for Forest Labs

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,619,007 Method and composition for administering an NMDA receptor antagonist to a subject ➤ Try a Free Trial
8,293,229 Methods of producing stable pancreatic enzyme compositions ➤ Try a Free Trial
2,012,045,508 ➤ Try a Free Trial
2,012,058,182 ➤ Try a Free Trial
8,426,472 Method and composition for administering an NMDA receptor antagonist to a subject ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Forest Labs Drugs

Supplementary Protection Certificates for Forest Labs Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB02/046 United Kingdom ➤ Try a Free Trial PRODUCT NAME: MEMANTINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS; REGISTERED: UK EU/1/02/219/001 20020515; UK EU/1/02/219/002 20020515; UK EU/1/02/219/003 20020515; UK EU/1/02/219/004 20020515; UK EU/1/02/219/005 20020515; UK EU/1/02/219/006 20020515
C/GB97/023 United Kingdom ➤ Try a Free Trial PRODUCT NAME: DONEPEZIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE HYDROCHLORIDE; REGISTERED: UK PL 10555/0006 19970214; UK PL 10555/0007 19970214
1998 Austria ➤ Try a Free Trial PRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214
02C/035 Belgium ➤ Try a Free Trial PRODUCT NAME: MEMANTINE; REGISTRATION NO/DATE: EU/1/02/219/001 20020517
C0038 France ➤ Try a Free Trial PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
C/GB10/012 United Kingdom ➤ Try a Free Trial PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Cipla
Mallinckrodt
Dow
Cerilliant
Citi
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot